InfuSystem Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Earnings (Loss) Per Share

Note 12 - Earnings (Loss) Per Share

3 Months Ended

Mar. 31, 2021

Notes to Financial Statements

Earnings Per Share [Text Block]

12.

Earnings (Loss) Per Share

Basic income per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted income per share assumes the issuance of potentially dilutive shares of common stock during the period. The following table reconciles the numerators and denominators of the basic and diluted income per share computations:

	Three Months Ended March 31,
Numerator:	2021		2020
Net income (loss) (in thousands)	$	661	$	(418	)
Denominator:
Weighted average common shares outstanding:
Basic		20,338,160		19,918,298
Dilutive effect of common stock equivalents		1,599,479		-
Diluted		21,937,639		19,918,298
Net income (loss) per share:
Basic	$	0.03	$	(0.02	)
Diluted	$	0.03	$	(0.02	)

For the three months ended March 31, 2021, less than 0.1 million of outstanding options and restricted stock units with an exercise price above the current market value of the Company’s common stock were not included in the calculation because they would have an anti-dilutive effect. For the three months ended March 31, 2020, all outstanding options and restricted stock units were anti-dilutive due to the Company’s net losses for the period and therefore not included in the calculation.